New Survey Sheds Light on Prescription Drug Use Among Women

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
New Survey Sheds Light on Prescription Drug Use Among Women After Surgery in the United States

PARSIPPANY, N.J., Nov. 17, 2015 (GLOBE NEWSWIRE) -- One in every 15 patients who receive prescription painkillers (also called opioids or narcotics) following surgery ends up using these medications long-term, 1 ,2 which can result in tolerance, dependence and addiction. According to a new national survey, a lack of doctor-patient communication about postsurgical pain management may be partly to blame. To help foster these important conversations, the Postsurgical Pain Control: Voice Your Choice   campaign was launched today to raise awareness of pain control choices and empower women to discuss treatment plans with their doctor before surgery. The campaign is a joint collaboration of Pacira Pharmaceuticals , a leader in providing pain control solutions for the acute care setting, HealthyWomen, a leading health information resource for women and Dr. Kristi Funk, renowned breast cancer surgeon and women’s health advocate.

The survey of more than 700 women in the United States who had undergone surgery found that while over 90 percent of respondents were aware of the risk of addiction to narcotics, and would prefer not to use them to manage pain after their procedure, 80 percent still did. And while the women surveyed unanimously indicated wanting a choice in how their pain is managed, less than a third (27%) initiated a discussion about options with their doctor.  “The women we surveyed were savvy about narcotic-related risks. In fact, over a third of them reported personally knowing someone who developed an addiction from postsurgical use. I find it worrisome that women aren’t expressing their concerns to their physicians, and as a result, are routinely receiving medications they prefer to avoid,” said Dr. Funk, a board-certified surgical breast specialist and founder of the Los Angeles-based Pink Lotus Breast Center. "Today, more than ever, we have several alternatives to effectively treat pain after surgery that can reduce or even eliminate the need for narcotics. The Voice Your Choice campaign aims to educate women about these options and encourage them to initiate a discussion with their physician about their preference in pain treatment before surgery.”  At the urging of public health officials and professional medical societies, physicians and hospitals are increasingly utilizing what is called a “multimodal approach” to manage pain after surgery, whereby a combination of medications are used before, during and after the procedure to block the various sources and pathways of pain. A typical multimodal regimen aimed at reducing the use of narcotics may include long-acting local anesthetics and anti-inflammatories such as ibuprofen, acetaminophen and aspirin.    “Women are often the primary healthcare decision-makers for themselves and their families, so it’s crucial for them to stay abreast of the latest medical advances so they can make informed choices,” said Beth Battaglino, R.N. and co-founder of HealthyWomen. “I encourage women to visit HealthyWomen.org/paincenter to learn more about non-narcotic pain management options after surgery, and access tools and resources to help foster a productive dialogue with their doctor.” About  Postsurgical Pain Control: Voice Your Choice  The Postsurgical Pain Control: Voice Your Choice campaign aims to raise awareness of pain control choices and empower women to discuss their treatment plan with their doctor before surgery. Visit http://healthywomen.org/paincenter  to learn more about postsurgical pain control options and how to Voice Your Choice with a physician. To join the conversation and share your stories please use #VoiceYourChoice on Twitter.

About the Survey HealthyWomen surveyed 744 female readers ages 21 and over, who have had surgery in the last 10 years. The online survey, conducted jointly by Pacira Pharmaceuticals and HealthyWomen, measured women’s experience and knowledge with narcotics and postsurgical pain. The survey was conducted May-June 2015.

About Dr. Kristi Funk Dr. Kristi Funk is board-certified surgical breast specialist who founded the Pink Lotus Breast Center in 2007. She is an expert in minimally-invasive diagnostic and treatment methods for all types of breast disease. She has helped thousands of women through breast cancer treatment, including well-known celebrities like Angelina Jolie and Sheryl Crow, who have turned to her for her expertise.

About HealthyWomen HealthyWomen (HW) is a leading nonprofit health information source for women. For nearly 25 years, women have been coming to HW for answers to their most pressing and personal health care questions. HW provides award-winning health information through a wide array of online content and print publications that are original, objective and reviewed and approved by medical experts. Its HON-certified website, www.HealthyWomen.org ®, has been recognized by ForbesWoman as one of the "Top 100 Websites for Women" for the third year in a row and was named the top women’s health website by Dr. Mehmet Oz in O, The Oprah Magazine. To learn more, visit www.HealthyWomen.org . About Pacira Pacira Pharmaceuticals, Inc. (NASDAQ: PCRX ) is a specialty pharmaceutical company focused on the clinical and commercial development of new products that meet the needs of acute care practitioners and their patients. The Company’s in-depth knowledge of the needs of the postsurgical pain market, coupled with its passion for delivering improved patient care, drives a corporate commitment to providing solutions that address unmet medical needs and improve clinical results. Additional information about Pacira is available at www.pacira.com .

1  Alam A, Gomes T, Zheng H, Mamdani MM, Juurlink DN, et al. Long-term analgesic use after low-risk surgery: a retrospective cohort study. Arch Intern Med. 2012;172(5):425-30.

2  Carroll I, Barelka P, Wang CK, Wang BM, Gillespie MJ, et al. A pilot cohort study of the determinants of longitudinal opioid use after surgery. Anesth Analg. 2012;115(3):694-702.

Company Contact: Pacira Pharmaceuticals, Inc. Jessica Cho, 973-254-3574 Media Contact: Pure Communications Susan Heins, 864-286-9597

Scroll down for more posts ▼

Top 10 Most Recent News Articles

AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 30

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 25

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 45

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 59

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading
Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 41

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 38

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading
Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 34

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading

Top 5 Most Recently Viewed Articles

Genesys Celebrates Global Recognition as a Top Workplace

Updated Category News Views 50

Genesys Achieves Global Recognition for Workplace Excellence Genesys, a renowned leader in AI-driven experience orchestration, has been proudly certified as a Great Place to Work. This significant accomplishment reflects the overwhelming sentiment from its employees, with a remarkable 90% affirming that Genesys is indeed a fantastic workplace. This statistic represents a...

Continue Reading
Class Action Alert for Twitter Stockholders: Important Updates

Updated Category News Views 198

Understanding the Class Action Lawsuit for Twitter, Inc. Stockholders A significant class action lawsuit has been initiated for individuals and entities who traded Twitter, Inc. stock or options during a specified period. This legal action has garnered substantial attention as it affects numerous investors who believe they suffered losses due to alleged misconduct. Key...

Continue Reading
Rhythm Pharmaceuticals Advances IMCIVREE® for Young Patients

Updated Category News Views 180

Rhythm Pharmaceuticals Receives FDA Acceptance for Priority Review Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a biopharmaceutical company, has announced that the FDA has accepted its supplemental New Drug Application (sNDA) for IMCIVREE® (setmelanotide). This application has been designated for Priority Review by the FDA, which suggests that patients may gain timely...

Continue Reading
Understanding Market Trends Impacting NCR Atleos Corp's Future

Updated Category News Views 59

Market Sentiment Surrounding NCR Atleos Corp NCR Atleos Corp (NYSE: NATL) has recently caught the attention of investors as its short interest percentage has experienced a notable increase. Currently, approximately 3.76% of the company's shares have been sold short, which translates to about 3.01 million shares. This figure indicates that roughly 6.35% of all regular...

Continue Reading
Leslie’s, Inc. Reports Q2 Fiscal 2025 Earnings and Key Insights

Updated Category News Views 346

Financial Highlights from Leslie’s, Inc. In light of recent developments, Leslie’s, Inc. (NASDAQ: LESL), the premier name in pool and spa care in the U.S., has unveiled its financial results for the second quarter of fiscal year 2025. The company is dedicated to serving both residential and professional customers with quality products and exceptional service. CEO...

Continue Reading